 Study Outcomes Demonstrate Safety and Efficacy of Pantheris for Treatment of In-Stent Restenosis REDWOOD CITY, CA ACCESSWIRE October 7, 2021 Avinger, Inc. NASDAQ:AVGR, a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of Peripheral Artery Disease PAD, today announced that clinical data from the INSIGHT study were presented during the Late-Breaking Clinical Trials session at the VIVA Vascular InterVentional Advances conference in Las Vegas. The INSIGHT trial was designed to evaluate the safety and effectiveness of Avingers Pantheris image-guided atherectomy system for treating in-stent restenosis ISR in lower extremity arteries. 